Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp.
Sutani A, Nagai Y, Udagawa K, Uchida Y, Koyama N, Murayama Y, Tanaka T, Miyazawa H, Nagata M, Kanazawa M, Hagiwara K, Kobayashi K. Sutani A, et al. Br J Cancer. 2006 Dec 4;95(11):1483-9. doi: 10.1038/sj.bjc.6603466. Epub 2006 Nov 14. Br J Cancer. 2006. PMID: 17106442 Free PMC article. Clinical Trial.
Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers.
Tanaka T, Nagai Y, Miyazawa H, Koyama N, Matsuoka S, Sutani A, Huqun, Udagawa K, Murayama Y, Nagata M, Shimizu Y, Ikebuchi K, Kanazawa M, Kobayashi K, Hagiwara K. Tanaka T, et al. Among authors: sutani a. Cancer Sci. 2007 Feb;98(2):246-52. doi: 10.1111/j.1349-7006.2006.00377.x. Cancer Sci. 2007. PMID: 17233841 Free PMC article.
Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation.
Miyazawa H, Tanaka T, Nagai Y, Matsuoka M; Huqun; Sutani A, Udagawa K, Zhang J, Hirama T, Murayama Y, Koyama N, Ikebuchi K, Nagata M, Kanazawa M, Nukiwa T, Takenoshita S, Kobayashi K, Hagiwara K. Miyazawa H, et al. Among authors: sutani a. Cancer Sci. 2008 Mar;99(3):595-600. doi: 10.1111/j.1349-7006.2007.00706.x. Cancer Sci. 2008. PMID: 18271876 Free PMC article.
Frequency of and variables associated with the EGFR mutation and its subtypes.
Tanaka T, Matsuoka M, Sutani A, Gemma A, Maemondo M, Inoue A, Okinaga S, Nagashima M, Oizumi S, Uematsu K, Nagai Y, Moriyama G, Miyazawa H, Ikebuchi K, Morita S, Kobayashi K, Hagiwara K. Tanaka T, et al. Among authors: sutani a. Int J Cancer. 2010 Feb 1;126(3):651-5. doi: 10.1002/ijc.24746. Int J Cancer. 2010. PMID: 19609951
[Lung carcinoma].
Sutani A, Kobayashi K. Sutani A, et al. Gan To Kagaku Ryoho. 2006 May;33(5):590-4. Gan To Kagaku Ryoho. 2006. PMID: 16685153 Review. Japanese.
Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601).
Komiyama K, Kobayashi K, Minezaki S, Kotajima F, Sutani A, Kasai T, Mori K, Hoshi E, Takayanagi N, Koyama S, Eguchi K, Nakayama M, Kikuchi K; Kanto Respiratory Disease Study Group. Komiyama K, et al. Among authors: sutani a. Br J Cancer. 2012 Oct 23;107(9):1474-80. doi: 10.1038/bjc.2012.437. Epub 2012 Oct 2. Br J Cancer. 2012. PMID: 23033004 Free PMC article. Clinical Trial.
Ciliary ultrastructure in two sisters with Kartagener's syndrome.
Tanaka K, Sutani A, Uchida Y, Shimizu Y, Shimizu M, Akita M. Tanaka K, et al. Among authors: sutani a. Med Mol Morphol. 2007 Mar;40(1):34-9. doi: 10.1007/s00795-007-0354-y. Epub 2007 Mar 29. Med Mol Morphol. 2007. PMID: 17384988
51 results